share_log

Inspire Medical Systems, Inc.'s (NYSE:INSP) Profit Outlook

Inspire Medical Systems, Inc.'s (NYSE:INSP) Profit Outlook

Inspire 醫療系統有限公司”s(紐約證券交易所代碼:INSP)利潤展望
Simply Wall St ·  05/09 01:50

With the business potentially at an important milestone, we thought we'd take a closer look at Inspire Medical Systems, Inc.'s (NYSE:INSP) future prospects. Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The US$7.4b market-cap company announced a latest loss of US$21m on 31 December 2023 for its most recent financial year result. The most pressing concern for investors is Inspire Medical Systems' path to profitability – when will it breakeven? We've put together a brief outline of industry analyst expectations for the company, its year of breakeven and its implied growth rate.

由於該業務可能處於重要的里程碑,我們認爲應該仔細研究Inspire Medical Systems, Inc.'s(紐約證券交易所代碼:INSP)的未來前景。Inspire Medical Systems, Inc. 是一家醫療技術公司,專注於爲美國和國際上的阻塞性睡眠呼吸暫停(OSA)患者開發和商業化微創解決方案。這家市值爲74億美元的公司於2023年12月31日宣佈其最新財年業績虧損2100萬美元。投資者最緊迫的擔憂是Inspire Medical Systems的盈利之路——它何時會實現盈虧平衡?我們簡要概述了行業分析師對該公司、盈虧平衡年份和隱含增長率的預期。

According to the 17 industry analysts covering Inspire Medical Systems, the consensus is that breakeven is near. They anticipate the company to incur a final loss in 2024, before generating positive profits of US$24m in 2025. The company is therefore projected to breakeven just over a year from now. In order to meet this breakeven date, we calculated the rate at which the company must grow year-on-year. It turns out an average annual growth rate of 52% is expected, which signals high confidence from analysts. If this rate turns out to be too aggressive, the company may become profitable much later than analysts predict.

根據報道Inspire Medical Systems的17位行業分析師的說法,人們的共識是盈虧平衡已臨近。他們預計,該公司將在2024年蒙受最終虧損,然後在2025年產生2400萬美元的正利潤。因此,預計該公司將在一年多後實現盈虧平衡。爲了達到這個盈虧平衡日期,我們計算了公司必須同比增長的速度。事實證明,預計年均增長率爲52%,這表明分析師充滿信心。如果事實證明這個利率過於激進,該公司的盈利時間可能比分析師預測的要晚得多。

earnings-per-share-growth
NYSE:INSP Earnings Per Share Growth May 8th 2024
紐約證券交易所:INSP 每股收益增長 2024 年 5 月 8 日

Given this is a high-level overview, we won't go into details of Inspire Medical Systems' upcoming projects, though, bear in mind that generally a high growth rate is not out of the ordinary, particularly when a company is in a period of investment.

鑑於這是一個高層次的概述,我們不會詳細介紹Inspire Medical Systems即將推出的項目,但請記住,總體而言,高增長率並非不尋常,尤其是在公司處於投資期時。

One thing we'd like to point out is that Inspire Medical Systems has no debt on its balance sheet, which is rare for a loss-making growth company, which typically has high debt relative to its equity. The company currently operates purely off its shareholder funding and has no debt obligation, reducing concerns around repayments and making it a less risky investment.

我們想指出的一件事是,Inspire Medical Systems的資產負債表上沒有債務,這對於虧損的成長型公司來說是罕見的,因爲相對於股權而言,債務通常很高。該公司目前完全靠股東資金運營,沒有債務義務,這減少了對還款的擔憂,使其成爲一項風險較小的投資。

Next Steps:

後續步驟:

There are too many aspects of Inspire Medical Systems to cover in one brief article, but the key fundamentals for the company can all be found in one place – Inspire Medical Systems' company page on Simply Wall St. We've also compiled a list of pertinent aspects you should look at:

Inspire Medical Systems的很多方面都無法在一篇簡短的文章中介紹,但該公司的關鍵基礎知識都可以在一個地方找到——Inspire Medical Systems的公司頁面Simply Wall St. 我們還整理了一份你應該考慮的相關方面清單:

  1. Valuation: What is Inspire Medical Systems worth today? Has the future growth potential already been factored into the price? The intrinsic value infographic in our free research report helps visualize whether Inspire Medical Systems is currently mispriced by the market.
  2. Management Team: An experienced management team on the helm increases our confidence in the business – take a look at who sits on Inspire Medical Systems's board and the CEO's background.
  3. Other High-Performing Stocks: Are there other stocks that provide better prospects with proven track records? Explore our free list of these great stocks here.
  1. 估值:Inspire 醫療系統今天的價值是多少?價格中是否已經考慮了未來的增長潛力?我們的免費研究報告中的內在價值信息圖有助於可視化Inspire Medical Systems目前是否被市場錯誤定價。
  2. 管理團隊:一支經驗豐富的管理團隊掌舵增強了我們對業務的信心——看看誰是Inspire Medical Systems董事會成員以及首席執行官的背景。
  3. 其他表現優異的股票:還有其他股票可以提供更好的前景並有良好的往績記錄嗎?在這裏瀏覽我們免費列出的這些優質股票。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論